A differential expression of IL-13, G-CSF, CCL11, IL-6 and IL-4 among patients at different stages of hepatic steatosis, highlighted a possible role of an inflammatory response in the development of hepatic steatosis and fibrosis in CHB patients. The gene discussed is IL4; the disease is fatty liver disease.